Dan

Equibles does not estimate personal net worth.

Get an email with a short summary when Cytokinetics Inc publishes a filing, an earnings call transcript or a press release.

Get CYTK alerts

About Dan

Dan has spoken on 1 investor event across 1 company, most recently for Cytokinetics Inc on May 19, 2026. Cytokinetics Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Cytokinetics Inc includes Robert Blum (CEO), Robert I. Blum (CEO and Board Member), John T. Henderson, M.D. (Chairman) and 7 others.

Dan on recent calls

“So we've had some preliminary feedback just from our academic steering committee, from KOL's heart failure space, and others around the world that we met with in Barcelona at the HFA meeting last week.”

Other, 2026 RBC Capital Markets Global Healthcare Conference · May 19, 2026

Affiliation history

Cytokinetics Inc (CYTK)
Transcript header (unverified)

Current

Company network

Cytokinetics Inc

CYTK

Current role

Biotechnology · Healthcare

1 appearance Latest appearance 2026-05-19

View calls and events

Leadership on record at Cytokinetics Inc

Robert Blum CEO
Robert I. Blum CEO, Board Member
John T. Henderson, M.D. Chairman
Sung H. Lee CFO
Brett Pletcher General Counsel
Jeffrey J. Hessekiel General Counsel
Mark A. Schlossberg General Counsel
Mr. Schlossberg General Counsel
Mr. Wong Chief Accounting Officer
Robert Wong Chief Accounting Officer

Recent activity

Conference 2026 RBC Capital Markets Global Healthcare Conference Cytokinetics Inc (CYTK)
2026-05-19